These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30931660)

  • 1. Mass spectrometry in emergency toxicology: Current state and future applications.
    Van Wijk XMR; Goodnough R; Colby JM
    Crit Rev Clin Lab Sci; 2019 Jun; 56(4):225-238. PubMed ID: 30931660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology.
    Wu AH; Gerona R; Armenian P; French D; Petrie M; Lynch KL
    Clin Toxicol (Phila); 2012 Sep; 50(8):733-42. PubMed ID: 22888997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using molecular similarity to highlight the challenges of routine immunoassay-based drug of abuse/toxicology screening in emergency medicine.
    Krasowski MD; Pizon AF; Siam MG; Giannoutsos S; Iyer M; Ekins S
    BMC Emerg Med; 2009 Apr; 9():5. PubMed ID: 19400959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limitations of point-of-care testing in the ED or ICU: a role for regional centralized toxicology laboratories.
    Wu AH
    Clin Pharmacol Ther; 2010 Sep; 88(3):295-8. PubMed ID: 20725077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-resolution mass spectrometry in toxicology: current status and future perspectives.
    Maurer HH; Meyer MR
    Arch Toxicol; 2016 Sep; 90(9):2161-2172. PubMed ID: 27369376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National academy of clinical biochemistry laboratory medicine practice guidelines: recommendations for the use of laboratory tests to support poisoned patients who present to the emergency department.
    Wu AH; McKay C; Broussard LA; Hoffman RS; Kwong TC; Moyer TP; Otten EM; Welch SL; Wax P;
    Clin Chem; 2003 Mar; 49(3):357-79. PubMed ID: 12600948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current state-of-the-art approaches for mass spectrometry in clinical toxicology: an overview.
    Peters FT; Wissenbach D
    Expert Opin Drug Metab Toxicol; 2023; 19(8):487-500. PubMed ID: 37615282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current and future applications of mass spectrometry to the clinical laboratory.
    Strathmann FG; Hoofnagle AN
    Am J Clin Pathol; 2011 Oct; 136(4):609-16. PubMed ID: 21917684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between drug screening by immunoassay and ultra-high performance liquid chromatography/high-resolution time-of-flight mass spectrometry in post-mortem urine.
    Sundström M; Pelander A; Ojanperä I
    Drug Test Anal; 2015 May; 7(5):420-7. PubMed ID: 24953563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
    Allen D; Rixson L
    Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Benefits of Direct-to-Definitive Testing for Monitoring Compliance in Pain Management.
    Gencheva R; Petrides A; Kantartjis M; Tanasijevic M; Dahlin JL; Melanson S
    Pain Physician; 2018 Nov; 21(6):E583-E592. PubMed ID: 30508989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Critical analysis of different methods used for toxicology screening in emergency laboratory].
    Pechard A; Besson AS; Mialon A; Berny C; Manchon M
    Ann Biol Clin (Paris); 1999; 57(5):525-37. PubMed ID: 10518054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telemedicine for the Medicare population: pediatric, obstetric, and clinician-indirect home interventions.
    Hersh WR; Wallace JA; Patterson PK; Shapiro SE; Kraemer DF; Eilers GM; Chan BK; Greenlick MR; Helfand M
    Evid Rep Technol Assess (Summ); 2001 Aug; (24 Suppl):1-32. PubMed ID: 11569328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.